FibroBiologics presents psoriasis data at dermatology meeting
FibroBiologics Inc. (NASDAQ: FBLG) presented preclinical data for its CYPS317 psoriasis treatment program at the Society for Investigative Dermatology 2026 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
